Background: Stroke is considered the second leading cause of mortality and disability worldwide. The increasing burden of stroke is strong evidence that currently used primary prevention strategies are not sufficiently effective. The Stroke Riskometer application (app) represents a new stroke prevention strategy distinctly different from the conventional high-cardiovascular disease risk approach. Objective: This proposed study aims to evaluate the effectiveness of the Stroke Riskometer app in improving stroke awareness and stroke risk probability amongst the adult population in Malaysia. Methods: A non-blinded, parallel-group cluster-randomized controlled trial with a 1:1 allocation ratio will be implemented in Kelantan, Malaysia. Two groups with a sample size of 66 in each group will be recruited. The intervention group will be equipped with the Stroke Riskometer app and informational leaflets, while the control group will be provided with standard management, including information leaflets only. The Stroke Riskometer app was developed according to the self-management model of chronic diseases based on self-regulation and social cognitive theories. Data collection will be conducted at baseline and on the third week, sixth week, and sixth month follow-up via telephone interview or online questionnaire survey. The primary outcome measure is stroke risk awareness, including the domains of knowledge, perception, and intention to change. The secondary outcome measure is stroke risk probability within 5 and 10 years adjusted to each participant’s socio-demographic and/or socio-economic status. An intention-to-treat approach will be used to evaluate these measures. Pearson’s χ2 or independent t test will be used to examine differences between the intervention and control groups. The generalized estimating equation and the linear mixed-effects model will be employed to test the overall effectiveness of the intervention. Conclusion: This study will evaluate the effect of Stroke Riskometer app on stroke awareness and stroke probability and briefly evaluate participant engagement to a pre-specified trial protocol. The findings from this will inform physicians and public health professionals of the benefit of mobile technology intervention and encourage more active mobile phone-based disease prevention apps. Trial Registration:ClinicalTrials.gov Identifier NCT04529681.

1.
Oʼdonnell
MJ
,
Xavier
D
,
Liu
L
,
Zhang
H
,
Chin
SL
,
Rao-Melacini
P
,
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study
.
Lancet
.
2010
;
376
(
9735
):
112
23
. .
2.
WHO
.
Cardiovascular diseases (CVDs)
.
2017 May 17
[cited 2020 September 5]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
3.
Lutski
M
,
Zucker
I
,
Shohat
T
,
Tanne
D
.
Characteristics and outcomes of young patients with first-ever ischemic stroke compared to older patients: the National Acute Stroke ISraeli Registry
.
Front Neurol
.
2017
;
8
:
421
. .
4.
Maaijwee
NA
,
Rutten-Jacobs
LC
,
Schaapsmeerders
P
,
van Dijk
EJ
,
de Leeuw
FE
.
Ischaemic stroke in young adults: risk factors and long-term consequences
.
Nat Rev Neurol
.
2014
;
10
(
6
):
315
. .
5.
Maaijwee
NA
,
Tendolkar
I
,
Rutten-Jacobs
LC
,
Arntz
RM
,
Schaapsmeerders
P
,
Dorresteijn
LD
,
Long-term depressive symptoms and anxiety after transient ischaemic attack or ischaemic stroke in young adults
.
Eur J Neurol
.
2016
;
23
(
8
):
1262
8
. .
6.
Yamamoto
FI
.
Ischemic stroke in young adults: an overview of etiological aspects
.
Arq Neuropsiquiatr
.
2012
;
70
(
6
):
462
6
. .
7.
Feigin
VL
,
Norrving
B
,
George
MG
,
Foltz
JL
,
Roth
GA
,
Mensah
GA
.
Prevention of stroke: a strategic global imperative
.
Nat Rev Neurol
.
2016
;
12
(
9
):
501
. .
8.
OʼDonnell
MJ
,
Chin
SL
,
Rangarajan
S
,
Xavier
D
,
Liu
L
,
Zhang
H
,
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
.
Lancet
.
2016
;
388
(
10046
):
761
75
. .
9.
Joseph
P
,
Leong
D
,
McKee
M
,
Anand
SS
,
Schwalm
JD
,
Teo
K
,
Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors
.
Circ Res
.
2017
;
121
(
6
):
677
94
. .
10.
Leong
DP
,
Joseph
PG
,
McKee
M
,
Anand
SS
,
Teo
KK
,
Schwalm
JD
,
Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease
.
Circ Res
.
2017
;
121
(
6
):
695
710
. .
11.
Lee
M
,
Lee
H
,
Kim
Y
,
Kim
J
,
Cho
M
,
Jang
J
,
Mobile app-based health promotion programs: a systematic review of the literature
.
Ijerph
.
2018
;
15
(
12
):
2838
. .
12.
Schoeppe
S
,
Alley
S
,
Van Lippevelde
W
,
Bray
NA
,
Williams
SL
,
Duncan
MJ
,
Efficacy of interventions that use apps to improve diet, physical activity and sedentary behaviour: a systematic review
.
Int J Behav Nutr Phys Act
.
2016
;
13
(
1
):
127
. .
13.
Payne
HE
,
Lister
C
,
West
JH
,
Bernhardt
JM
.
Behavioral functionality of mobile apps in health interventions: a systematic review of the literature
.
JMIR Mhealth Uhealth
.
2015
;
3
(
1
):
e20
. .
14.
King
AC
,
Hekler
EB
,
Grieco
LA
,
Winter
SJ
,
Sheats
JL
,
Buman
MP
,
Harnessing different motivational frames via mobile phones to promote daily physical activity and reduce sedentary behavior in aging adults
.
PLoS One
.
2013
;
8
(
4
):
e62613
. .
15.
Kirwan
M
,
Duncan
MJ
,
Vandelanotte
C
,
Mummery
WK
.
Using smartphone technology to monitor physical activity in the 10,000 Steps program: a matched case–control trial
.
J Med Internet Res
.
2012
;
14
(
2
):
e55
.
16.
Turner-McGrievy
GM
,
Beets
MW
,
Moore
JB
,
Kaczynski
AT
,
Barr-Anderson
DJ
,
Tate
DF
.
Comparison of traditional versus mobile app self-monitoring of physical activity and dietary intake among overweight adults participating in an mHealth weight loss program
.
J Am Med Inform Assoc
.
2013
;
20
(
3
):
513
8
. .
17.
Feigin
VL
,
Norrving
B
.
A new paradigm for primary prevention strategy in people with elevated risk of stroke
.
Int J Stroke
.
2014
;
9
(
5
):
624
6
. .
18.
Feigin
VL
,
Krishnamurthi
R
,
Bhattacharjee
R
,
Parmar
P
,
Theadom
A
,
Hussein
T
,
New strategy to reduce the global burden of stroke
.
Stroke
.
2015
;
46
(
6
):
1740
7
. .
19.
Feigin
VL
,
Wang
W
,
Fu
H
,
Liu
L
,
Krishnamurthi
R
,
Bhattacharjee
R
,
Primary stroke prevention in China: a new approach
.
Neurol Res
.
2015
;
37
(
5
):
378
80
. .
20.
Allegrante
JP
,
Wells
MT
,
Peterson
JC
.
Interventions to support behavioral self-management of chronic diseases
.
Annu Rev Public Health
.
2019
;
40
:
127
46
. .
21.
22.
Ministry of Health Malaysia
.
Clinical practice guidelines
. 5th ed.
2018
[cited 2019]. Available from: https://www.moh.gov.my/moh/resources/penerbitan/CPG/MSH%20Hypertension%20CPG%202018%20V3.8%20FA.pdf.
23.
Erdfelder
E
,
Faul
F
,
Buchner
A
.
GPOWER: a general power analysis program
.
Behav Res Methods Instrum Comput
.
1996
;
28
(
1
):
1
11
. .
24.
Campbell
MK
,
Grimshaw
JM
,
Elbourne
DR
.
Intracluster correlation coefficients in cluster randomized trials: empirical insights into how should they be reported
.
BMC Med Res Methodol
.
2004
;
4
(
1
):
9
. .
25.
Kul
S
,
Vanhaecht
K
,
Panella
M
.
Intraclass correlation coefficients for cluster randomized trials in care pathways and usual care: hospital treatment for heart failure
.
BMC Health Serv Res
.
2014
;
14
(
1
):
84
7
. .
26.
Murray
DM
,
Catellier
DJ
,
Hannan
PJ
,
Treuth
MS
,
Stevens
J
,
Schmitz
KH
,
School-level intraclass correlation for physical activity in adolescent girls
.
Med Sci Sports Exerc
.
2004
;
36
(
5
):
876
. .
27.
Rotondi
M
,
Donner
A
.
Sample size estimation in cluster randomized trials: an evidence-based perspective
.
Comput Stat Data Anal
.
2012
;
56
(
5
):
1174
87
. .
28.
Urbaniak
G
,
Plous
S
.
Research randomizer (version 4.0) [computer software]
.
2013
.
29.
Krishnamurthi
R
,
Hale
L
,
Barker-Collo
S
,
Theadom
A
,
Bhattacharjee
R
,
George
A
,
Mobile technology for primary stroke prevention: a proof-of-concept pilot randomized controlled trial
.
Stroke
.
2019
;
50
(
1
):
196
8
.
30.
Feigin
V
.
Stroke riskometer
. [cited 2019 Oct 20]. Available from: https://www.strokeriskometer.com/.
31.
Ministry of Health Malaysia
.
Media sihat
.
2017
[cited 2020 Sep 5]. Available from: https://www.infosihat.gov.my/index.php/component/zoo/item/angin-ahmar-2.
32.
Bandura
A
.
Health promotion by social cognitive means
.
Health Educ Behav
.
2004
;
31
(
2
):
143
64
. .
33.
Clark
NM
,
Gong
M
,
Kaciroti
N
.
A model of self-regulation for control of chronic disease
.
Health Educ Behav
.
2001
;
28
(
6
):
769
82
. .
34.
WHO
.
Preventing chronic diseases: a vital investment
.
World Health Organization
;
2005
.
35.
Parmar
P
,
Krishnamurthi
R
,
Ikram
MA
,
Hofman
A
,
Mirza
SS
,
Varakin
Y
,
The Stroke Riskometer TM app: validation of a data collection tool and stroke risk predictor
.
Int J Stroke
.
2015
;
10
(
2
):
231
44
.
36.
Woringer
M
,
Nielsen
JJ
,
Zibarras
L
,
Evason
J
,
Kassianos
AP
,
Harris
M
,
Development of a questionnaire to evaluate patientsʼ awareness of cardiovascular disease risk in Englandʼs National Health Service Health Check preventive cardiovascular programme
.
BMJ Open
.
2017
;
7
(
9
):
e014413
. .
37.
Glanz
K
,
Rimer
BK
,
Viswanath
K
.
Health behavior and health education: theory, research, and practice
John Wiley & Sons
;
2008
.
38.
Prochaska
JO
,
Redding
CA
,
Evers
KE
,
The transtheoretical model and stages of change
. In:
Glanz
K
,
Rimer
BK
,
Viswanath
KV
, editors.
Health behavior: theory, research, and practice
.
Jossey-Bass/Wiley
;
2015
. p.
125
48
.
39.
Gardois
P
,
Booth
A
,
Goyder
E
,
Ryan
T
.
Health promotion interventions for increasing stroke awareness in ethnic minorities: a systematic review of the literature
.
BMC public health
.
2014
;
14
(
1
):
409
. .
40.
Guertler
D
,
Vandelanotte
C
,
Kirwan
M
,
Duncan
MJ
.
Engagement and nonusage attrition with a free physical activity promotion program: the case of 10,000 steps Australia
.
J Med Internet Res
.
2015
;
17
(
7
):
e176
. .
41.
Harris
PA
,
Taylor
R
,
Minor
BL
,
Elliott
V
,
Fernandez
M
,
OʼNeal
L
,
The REDCap consortium: building an international community of software platform partners
.
J Biomed Inform
.
2019
;
95
:
103208
. .
42.
Harris
PA
,
Taylor
R
,
Thielke
R
,
Payne
J
,
Gonzalez
N
,
Conde
JG
.
Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support
.
J Biomed Inform
.
2009
;
42
(
2
):
377
81
.
43.
R Core Team
.
A language and environment for statistical computing
;
2013
.
44.
Brown
VA
.
An introduction to linear mixed-effects modeling in R
.
Adv Meth Pract Psychol Sci
.
2021
;
4
(
1
):
251524592096035
. .
45.
Musekiwa
A
,
Manda
SO
,
Mwambi
HG
,
Chen
DG
.
Meta-analysis of effect sizes reported at multiple time points using general linear mixed model
.
PLoS One
.
2016
;
11
(
10
):
e0164898
. .
46.
Naseri
P
,
Alavi Majd
H
,
Kariman
N
,
Sourtiji
A
.
Comparison of generalized estimating equations (GEE), mixed effects models (MEM) and repeated measures ANOVA in analysis of menorrhagia data
.
Arch Adv Biosci
.
2016
;
7
(
1
):
32
40
.
47.
Chakraborty
H
,
Gu
H
.
A mixed model approach for intent-to-treat analysis in longitudinal clinical trials with missing values
.
2019
.
48.
Halekoh
U
,
Højsgaard
S
,
Yan
J
.
The R packagegeepackfor generalized estimating equations
.
J Stat Soft
.
2006
;
15
(
2
):
1
11
. .
49.
Pinheiro
J
,
Bates
D
,
DebRoy
S
,
Sarkar
D
.
Linear and nonlinear mixed effects models
. R Package Version.
2007
;
3
(
57
):
1
89
.
50.
Yan
J
,
Fine
J
.
Estimating equations for association structures
.
Stat Med
.
2004
;
23
(
6
):
859
80
. .
51.
Diggle
P
,
Zeger
SL
,
Liang
KY
,
Heagerty
P
.
Analysis of longitudinal data
. 2nd ed.
Oxford statistical science series
.
Oxford University Press
;
2002
.
52.
R Core Team
.
R: a language and environment for statistical computing
.
2013
. Available from: http://www.R-project.org/.
53.
Twisk
JW
.
Applied longitudinal data analysis for epidemiology: a practical guide
.
Cambridge University Press
;
2013
.
54.
Nussbaum
R
,
Kelly
C
,
Quinby
E
,
Mac
A
,
Parmanto
B
,
Dicianno
BE
.
Systematic review of mobile health applications in rehabilitation
.
Arch Phys Med Rehabil
.
2019
;
100
(
1
):
115
27
. .
55.
Lee
JW
,
Lim
HS
,
Kim
DW
,
Shin
SA
,
Kim
J
,
Yoo
B
,
The development and implementation of stroke risk prediction model in National Health Insurance Service's personal health record
.
Comput Methods Programs Biomed
.
2018
;
153
:
253
7
. .
56.
Wang
Y
,
Liu
J
,
Wang
W
,
Wang
M
,
Qi
Y
,
Xie
W
,
Lifetime risk of stroke in young-aged and middle-aged Chinese population: the Chinese Multi-Provincial Cohort Study
.
J Hypertens
.
2016
;
34
(
12
):
2434
. .
57.
Barlow
J
,
Wright
C
,
Sheasby
J
,
Turner
A
,
Hainsworth
J
.
Self-management approaches for people with chronic conditions: a review
.
Patient Educ Couns
.
2002
;
48
(
2
):
177
87
. .
58.
Han
M
,
Lee
E
.
Effectiveness of mobile health application use to improve health behavior changes: a systematic review of randomized controlled trials
.
Healthc Inform Res
.
2018
;
24
(
3
):
207
26
. .
59.
Mummah
S
,
Robinson
TN
,
Mathur
M
,
Farzinkhou
S
,
Sutton
S
,
Gardner
CD
.
Effect of a mobile app intervention on vegetable consumption in overweight adults: a randomized controlled trial
.
Int J Behav Nutr Phys Act
.
2017
;
14
(
1
):
125
. .
60.
WHO
.
WHO guideline: recommendations on digital interventions for health system strengthening: web supplement 2: summary of findings and GRADE tables
.
World Health Organization
;
2019
.
61.
Singal
AG
,
Higgins
PD
,
Waljee
AK
.
A primer on effectiveness and efficacy trials
.
Clin Transl Gastroenterol
.
2014
;
5
(
1
):
e45
. .
62.
Vickers
AJ
.
How many repeated measures in repeated measures designs? Statistical issues for comparative trials
.
BMC Med Res Methodol
.
2003
;
3
(
1
):
22
. .
63.
Butland
B
,
Kopelman
P
,
Jebb
SA
.
Tackling obesities: future choices-project report
.
Department of Innovation, Universities and Skills London
;
2007
.
Vol. 10
.
64.
Zhang
H
,
Jiang
Y
,
Nguyen
HD
,
Poo
DC
,
Wang
W
.
The effect of a smartphone-based coronary heart disease prevention (SBCHDP) programme on awareness and knowledge of CHD, stress, and cardiac-related lifestyle behaviours among the working population in Singapore: a pilot randomized controlled trial
.
Health Qual Life Outcomes
.
2017
;
15
(
1
):
49
.
65.
Palmer
M
,
Sutherland
J
,
Barnard
S
,
Wynne
A
,
Rezel
E
,
Doel
A
,
The effectiveness of smoking cessation, physical activity/diet and alcohol reduction interventions delivered by mobile phones for the prevention of non-communicable diseases: a systematic review of randomized controlled trials
.
PLoS One
.
2018
;
13
(
1
):
e0189801
.
66.
Beratarrechea
A
,
Lee
AG
,
Willner
JM
,
Jahangir
E
,
Ciapponi
A
,
Rubinstein
A
.
The impact of mobile health interventions on chronic disease outcomes in developing countries: a systematic review
.
Telemed J E Health
.
2014
;
20
(
1
):
75
82
. .
67.
Man-Son-Hing
M
,
Laupacis
A
,
OʼRourke
K
,
Molnar
FJ
,
Mahon
J
,
Chan
KB
,
Determination of the clinical importance of study results
.
J Gen Intern Med
.
2002
;
17
(
6
):
469
76
. .
68.
Suresh
K
,
Chandrashekara
S
.
Sample size estimation and power analysis for clinical research studies
.
J Hum Reprod Sci
.
2012
;
5
(
1
):
7
. .
69.
Wittes
J
.
Sample size calculations for randomized controlled trials
.
Epidemiol Rev
.
2002
;
24
(
1
):
39
53
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.